Cost-Effectiveness of Neoadjuvant Pembrolizumab Plus Chemotherapy Followed by Adjuvant Single-Agent Pembrolizumab for High-Risk Early-Stage Triple-Negative Breast Cancer in the Uni...

por Huang, Min, A. Fasching, Peter, Haiderali, Amin, Xue, Weiguang, Yang, Chelsey, Pan, Wilbur, Zhou, Zheng-Yi, Hu, Peter, Chaudhuri, Mitashri, Le Bailly De Tilleghem, Celine, Cappoen, Nicolas, O’Shaughnessy, Joyce
Publicado 2023

Predicting Prognosis of Breast Cancer Patients with Brain Metastases in the BMBC Registry—Comparison of Three Different GPA Prognostic Scores

por Riecke, Kerstin, Müller, Volkmar, Weide, Rudolf, Schmidt, Marcus, Park-Simon, Tjoung-Won, Möbus, Volker, Mundhenke, Christoph, Polasik, Arkadius, Lübbe, Kristina, Hesse, Tobias, Laakmann, Elena, Thill, Marc, A. Fasching, Peter, Denkert, Carsten, Fehm, Tanja, Nekljudova, Valentina, Rey, Julia, Loibl, Sibylle, Witzel, Isabell
Publicado 2021